Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.4349
+0.02486.05%
Pre-market: 0.46000.0251+5.77%04:01 EDT
Volume:6.26M
Turnover:2.68M
Market Cap:50.60M
PE:-0.30
High:0.4504
Open:0.4100
Low:0.4000
Close:0.4101
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

Applied Therapeutics files Form 12b-25 with SEC

TIPRANKS
·
31 Mar

Applied Therapeutics appoints Baumgartner as Chief Regulatory Officer

TIPRANKS
·
19 Mar

Applied Therapeutics Appoints Todd F. Baumgartner, Md, Mph as Chief Regulatory Officer

THOMSON REUTERS
·
19 Mar

Press Release: Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Dow Jones
·
19 Mar

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

Zacks
·
21 Feb

BRIEF-Applied Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance

Reuters
·
10 Feb

Applied Therapeutics Inc - Receives Nasdaq Notice for Minimum Bid Price Non-Compliance

THOMSON REUTERS
·
10 Feb

Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality

THOMSON REUTERS
·
21 Jan

Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey
·
06 Jan

Top Calls on Wall Street: Pony AI, Thermo Fisher, Aclaris Therapeutics, and More

The Fly
·
23 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
23 Dec 2024

William Blair Downgrades Applied Therapeutics to Market Perform From Outperform

MT Newswires Live
·
23 Dec 2024

Applied Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones
·
23 Dec 2024

William Blair downgrades Applied Therapeutics (APLT) to a Hold

TIPRANKS
·
23 Dec 2024

Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data

Benzinga
·
20 Dec 2024

Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO

MT Newswires Live
·
20 Dec 2024

RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
20 Dec 2024

Applied Therapeutics CEO Shendelman Steps Down

Dow Jones
·
20 Dec 2024

BRIEF-Applied Therapeutics Appoints John H. Johnson As Executive Chairman

Reuters
·
20 Dec 2024

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

THOMSON REUTERS
·
20 Dec 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."